DNA Link Email Format
Biotechnology ResearchSeoul, South Korea11-50 Employees
DNA Link is a Seoul-based biotechnology research company focused on medical genetics. It collaborates with Korea’s leading clinical research specialists to study how genetic factors influence diseases such as diabetes, cardiovascular disease, cancer, atopy, and digestive disorders. Informed by advances in genomic science, the company uses genome-wide analyses to explore links between disease and genetic content and to support the development of diagnostic systems and personalized treatment strategies, including cancer diagnostics that look for copy-number variants. Operating as a small to mid-sized firm, DNA Link positions itself within Korea’s biomedical research ecosystem through deep collaborations with clinical researchers. A concrete recent development is a September 2023 partnership with SomaLogic to offer the SomaScan platform to DNA Link’s customers, expanding access to high-throughput proteomics-enabled insights.